These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 12495738)

  • 1. Cross priming or direct priming: is that really the question?
    Norbury CC; Sigal LJ
    Curr Opin Immunol; 2003 Feb; 15(1):82-8. PubMed ID: 12495738
    [No Abstract]   [Full Text] [Related]  

  • 2. Coupling and cross-presentation.
    Heath WR; Carbone FR
    Nature; 2005 Mar; 434(7029):27-8. PubMed ID: 15744280
    [No Abstract]   [Full Text] [Related]  

  • 3. On cross-priming of MHC class I-specific CTL: rule or exception?
    Zinkernagel RM
    Eur J Immunol; 2002 Sep; 32(9):2385-92. PubMed ID: 12207322
    [No Abstract]   [Full Text] [Related]  

  • 4. Immunology. Accessory to murder.
    Schumacher TN
    Nature; 1999 Mar; 398(6722):26-7. PubMed ID: 10078525
    [No Abstract]   [Full Text] [Related]  

  • 5. Presentation of native TROP-2 tumor antigens to human cytotoxic T lymphocytes by engineered antigen-presenting cells.
    Mangino G; Grazia Capri M; Barnaba V; Alberti S
    Int J Cancer; 2002 Oct; 101(4):353-9. PubMed ID: 12209960
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Redundancy of direct priming and cross-priming in tumor-specific CD8+ T cell responses.
    Wolkers MC; Stoetter G; Vyth-Dreese FA; Schumacher TN
    J Immunol; 2001 Oct; 167(7):3577-84. PubMed ID: 11564769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Artificial antigen-presenting cells are superior to dendritic cells at inducing antigen-specific cytotoxic T lymphocytes.
    Shao J; Xu Q; Su S; Wei J; Meng F; Chen F; Zhao Y; Du J; Zou Z; Qian X; Liu B
    Cell Immunol; 2018 Dec; 334():78-86. PubMed ID: 30392890
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dendritic cells and antigen presentation in the regulation of cytotoxic T lymphocyte responses against viruses and transplantation antigens.
    Melief CJ; Boog CJ; Vasmel WL; Boes J; Voordouw AC; Kast WM
    Ann N Y Acad Sci; 1988; 532():280-91. PubMed ID: 2845847
    [No Abstract]   [Full Text] [Related]  

  • 9. [HCV-specific cytotoxic T lymphocyte and its epitope].
    Morita H; Imawari M
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):155-8. PubMed ID: 15359784
    [No Abstract]   [Full Text] [Related]  

  • 10. Roles of tumour localization, second signals and cross priming in cytotoxic T-cell induction.
    Ochsenbein AF; Sierro S; Odermatt B; Pericin M; Karrer U; Hermans J; Hemmi S; Hengartner H; Zinkernagel RM
    Nature; 2001 Jun; 411(6841):1058-64. PubMed ID: 11429607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Class I antigen presentation.
    Jelachich ML; Biddison WE
    Year Immunol; 1989; 4():41-58. PubMed ID: 2522701
    [No Abstract]   [Full Text] [Related]  

  • 12. Factors affecting the efficiency of CD8+ T cell cross-priming with exogenous antigens.
    Maecker HT; Ghanekar SA; Suni MA; He XS; Picker LJ; Maino VC
    J Immunol; 2001 Jun; 166(12):7268-75. PubMed ID: 11390476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Direct cross-priming by th lymphocytes generates memory cytotoxic T cell responses.
    Kennedy R; Undale AH; Kieper WC; Block MS; Pease LR; Celis E
    J Immunol; 2005 Apr; 174(7):3967-77. PubMed ID: 15778353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Making sense of mass destruction: quantitating MHC class I antigen presentation.
    Yewdell JW; Reits E; Neefjes J
    Nat Rev Immunol; 2003 Dec; 3(12):952-61. PubMed ID: 14647477
    [No Abstract]   [Full Text] [Related]  

  • 15. Quantitating presentation of MHC class I-restricted antigens.
    Chen W; Bennink JR; Yewdell JW
    Methods Mol Biol; 2001; 156():245-54. PubMed ID: 11068765
    [No Abstract]   [Full Text] [Related]  

  • 16. Antigen presentation to cytotoxic T lymphocytes in vivo.
    Bevan MJ
    J Exp Med; 1995 Sep; 182(3):639-41. PubMed ID: 7650475
    [No Abstract]   [Full Text] [Related]  

  • 17. Molecular and cellular requirements for enhanced antigen cross-presentation to CD8 cytotoxic T lymphocytes.
    Oizumi S; Strbo N; Pahwa S; Deyev V; Podack ER
    J Immunol; 2007 Aug; 179(4):2310-7. PubMed ID: 17675492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrathymic deletion of MHC class I-restricted cytotoxic T cell precursors by constitutive cross-presentation of exogenous antigen.
    Merkenschlager M; Power MO; Pircher H; Fisher AG
    Eur J Immunol; 1999 May; 29(5):1477-86. PubMed ID: 10359101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunology. Nothing 'gainst time's scythe can make defense..
    Ploegh HL
    Science; 2004 May; 304(5675):1262-3. PubMed ID: 15166355
    [No Abstract]   [Full Text] [Related]  

  • 20. Cross-presentation by intercellular peptide transfer through gap junctions.
    Neijssen J; Herberts C; Drijfhout JW; Reits E; Janssen L; Neefjes J
    Nature; 2005 Mar; 434(7029):83-8. PubMed ID: 15744304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.